Does ZELBORAF Cause Malignant neoplasm progression? 11 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 11 reports of Malignant neoplasm progression have been filed in association with ZELBORAF. This represents 3.1% of all adverse event reports for ZELBORAF.
11
Reports of Malignant neoplasm progression with ZELBORAF
3.1%
of all ZELBORAF reports
7
Deaths
2
Hospitalizations
How Dangerous Is Malignant neoplasm progression From ZELBORAF?
Of the 11 reports, 7 (63.6%) resulted in death, 2 (18.2%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ZELBORAF. However, 11 reports have been filed with the FAERS database.
What Other Side Effects Does ZELBORAF Cause?
Disease progression (62)
Death (49)
Rash (45)
Arthralgia (29)
Fatigue (17)
Nausea (16)
Asthenia (14)
Dysphagia (14)
Erythema (14)
Photosensitivity reaction (14)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which ZELBORAF Alternatives Have Lower Malignant neoplasm progression Risk?
ZELBORAF vs ZEMPLAR
ZELBORAF vs ZENATANE
ZELBORAF vs ZETIA
ZELBORAF vs ZICONOTIDE
ZELBORAF vs ZIDOVUDINE